PFE: Pfizer Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 133,435.53
Enterprise Value ($M) 194,701.53
Book Value ($M) 88,497.00
Book Value / Share 15.57
Price / Book 1.51
NCAV ($M) -71,530.00
NCAV / Share -12.58
Price / NCAV -1.87

Profitability (mra)
Return on Invested Capital (ROIC) 0.05
Return on Assets (ROA) 0.04
Return on Equity (ROE) 0.09

Liquidity (mrq)
Quick Ratio 0.96
Current Ratio 1.26

Balance Sheet (mrq) ($M)
Current Assets 45,861.00
Assets 208,028.00
Liabilities 117,391.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 63,627.00
Operating Income 16,328.00
Net Income 8,031.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 12,744.00
Cash from Investing 2,652.00
Cash from Financing -17,140.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 4,624,798 25,926,768 17.84
2025-05-29 3,844,282 21,309,444 18.04
2025-05-28 4,848,077 27,133,630 17.87
2025-05-27 5,549,280 26,940,046 20.60

(click for more detail)

Similar Companies
NUVB – Nuvation Bio Inc. OGN – Organon & Co.
PBH – Prestige Consumer Healthcare Inc. PRGO – Perrigo Company plc
QGEN – Qiagen N.V.


Financial data and stock pages provided by
Fintel.io